Burundi
Tuberculosis profile
| High HIV burden |
Population  2012 9.8 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 1.8 (0.79–3.2) 18 (8–32)
Mortality (HIV+TB only) 0.85 (0.7–1) 8.6 (7.1–10)
Prevalence  (includes HIV+TB) 20 (10–32) 199 (106–322)
Incidence  (includes HIV+TB) 13 (11–14) 130 (114–147)
Incidence (HIV+TB only) 2.5 (2.2–2.8) 25 (22–28)
Case detection, all forms (%) 54 (48–62)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 4 075 (61) Relapse 210 (69)
Smear-negative 667 (10) Treatment after failure 48 (16)
Smear-unknown / not done 79 (1) Treatment after default 47 (15)
Extrapulmonary 1 887 (28) Other 0 (0)
Other 3 (<1)      
Total new 6 711   Total retreatment 305  
           
Other (history unknown) 0        
Total new and relapse 6 921   Total cases notified 7 016  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.1 1.7 1.3
Age < 15 119 41 365
Laboratories 2012
Smear (per 100 000 population) 1.7
Culture (per 5 million population) 0.5
Drug susceptibility testing (per 5 million population) 0
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 92   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 84  
Retreatment 85  
TB/HIV 2012 Number (%)
TB patients with known HIV status 5 734 (82)
HIV-positive TB patients 1 076 (19)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 1 009 (94)
HIV-positive TB patients on antiretroviral therapy (ART) 588 (55)
HIV-positive people screened for TB 237  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.5 (0.01–5) 10 (3.5–17)
MDR-TB cases among notified pulmonary
TB cases
120 (0–240) 31 (11–52)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 1 (<1%) 23 (8%) 24
Laboratory-confirmed MDR-TB cases 1 23 24
Patients started on MDR-TB treatment     36
Financing TB control 2013
National TB programme budget (US$ millions)  
% Funded domestically  
% Funded internationally  
% Unfunded  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-23 Data: www.who.int/tb/data